All In Biotech

Drug Trial Radar · NCT00866944

Study of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver Metastases

A Randomized, Open-label, Controlled, Multi-center Phase II Study to Evaluate the Efficacy and Safety of Adecatumumab Alone or Sequentially to FOLFOX Relative to FOLFOX After R0 Resection of Colorectal Liver Metastases

Last checked: Nov 19, 2026Latest source record: Nov 11, 2011 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

35

Actual

Start

Mar 2009

Primary completion

Jul 2011

Study completion Nov 2011

Sponsor

Lead sponsor
Amgen Research (Munich) GmbHAmgen (AMGN)
Sponsor type
Industry
First posted
Mar 23, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine the effect of adecatumumab alone or following FOLFOX in patients with R0 resected liver metastases from CRC (colorectal carcinoma) and to compare the effect to FOLFOX alone.

Conditions

  • Liver Metastases
  • Colorectal Cancer

Interventions

  • AdecatumumabDrug

    Adecatumumab,6-9mg/kg, every 14 days, 24 cycles

  • Adecatumumab and FOLFOXDrug

    FOLFOX 4, every 14 days, 12 cycles followed by Adecatumumab, 6-9mg/kg, every 14 days, 12 cycles

  • FOLFOX 4Drug

    FOLFOX 4, every 14 days, 12 cycles

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Disease free survival rate (DFS)Time frame: 1 year

Locations

16 sites in 2 countries. Site status is shown where the registry gives one.

  • Centre Paul Strauss

    Strasbourg, France

  • Zentralklinikum Augsburg

    Augsburg, Germany

  • Klinikum am Bruderwald, Sozialstiftung Bamberg

    Bamberg, Germany

  • Charité Campus Virchow Klinikum

    Berlin, Germany

  • Klinikum der Heinrich-Heine Universität

    Düsseldorf, Germany

  • J.W. Goethe-Universität

    Frankfurt, Germany

  • Martin-Luther Universität

    Halle, Germany

  • Medizinische Hochschule Hannover

    Hanover, Germany

  • Universitätsklinikum Leipzig

    Leipzig, Germany

  • Klinikum Magdeburg gGmbH

    Magdeburg, Germany

  • Klinikum der Johannes-Gutenberg Universität

    Mainz, Germany

  • Klinikum Mannheim GmbH Universitätsklinikum

    Mannheim, Germany

  • Universitätsklinikum der LMU Grosshadern

    München, Germany

  • Städtisches Klinikum Neuperlach

    München, Germany

  • Klinikum Oldenburg gGmbH

    Oldenburg, Germany

  • Klinikum der Universität Regensburg

    Regensburg, Germany

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.